![Alois Waldburg-Zeil](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Alois Waldburg-Zeil
Directeur Général chez
CPH GROUP AG
Fortune : 234 582 $ au 30/06/2026
Profil
Alois Waldburg-Zeil currently works at CPH Group AG, as Group Chief Executive Officer from 2025, Zeochem AG, as Chief Executive Officer from 2010, and Canexis Pharma AG, as Director.
Dr. Waldburg-Zeil also formerly worked at Süd-Chemie Zeolites GmbH, as Chief Executive Officer, Sud Chemie UK Ltd., as Chief Executive Officer, Chemie Uetikon AG, as Director, Süd-Chemie AG, as Sales Manager from 1997 to 2009, KPMG Holding AG, as Auditor from 1993 to 1997, and Süd-Chemie Performance Packaging, as Group Financial Manager.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
CPH GROUP AG CLASS A 0,06 % | 31/12/2025 | 3 428 ( 0,06 % ) | 234 582 $ | 30/06/2026 |
Postes actifs de Alois Waldburg-Zeil
| Sociétés | Poste | Début |
|---|---|---|
| CPH GROUP AG | Directeur Général | 01/04/2025 |
Zeochem AG
 Zeochem AG Chemicals: SpecialtyProcess Industries Develops and produces chromatography gels | Directeur Général | 01/01/2010 |
Canexis Pharma AG
 Canexis Pharma AG Canexis Pharma AG is a Swiss GMP-certified company specializing in the production of medical cannabis and cannabis-based pharmaceuticals. The company is based in Schlattingen, Switzerland. The company integrates expertise in natural medicine, chemistry, and business informatics to advance cannabinoid science and patient care. Canexis operates a facility featuring cleanrooms and controlled environments compliant with EU and PIC/S GMP standards, and adheres to multiple pharmacopeias including the European, Swiss, and German pharmacopoeias. The company oversees the entire value chain, from seed selection and sustainable cultivation under GACP guidelines with partners, through in-house analytics and quality control, to manufacturing and distribution of active pharmaceutical ingredients and finished medicinal products. Manufacturing processes involve custom-built equipment and controlled steps such as extraction, distillation, and formulation, validated according to regulatory requirements. Canexis holds licenses for manufacturing, wholesale distribution, export, and handling of controlled substances, and offers solutions, training, and consulting in medical cannabis. | Directeur/Membre du Conseil | - |
Anciens postes connus de Alois Waldburg-Zeil
| Sociétés | Poste | Fin |
|---|---|---|
Süd-Chemie AG
 Süd-Chemie AG Chemicals: SpecialtyProcess Industries Manufactures inorganic chemical produtcs | Sales & Marketing | 01/01/2009 |
KPMG Holding AG
 KPMG Holding AG Miscellaneous Commercial ServicesCommercial Services Provides accounting services | Corporate Officer/Principal | 01/01/1997 |
Süd-Chemie Performance Packaging | Directeur Financier/CFO | - |
Süd-Chemie Zeolites GmbH | Directeur Général | - |
Sud Chemie UK Ltd. | Directeur Général | - |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
34
Relations au 1er degré
9
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 9 |
|---|---|
Süd-Chemie AG
Süd-Chemie AG Chemicals: SpecialtyProcess Industries Manufactures inorganic chemical produtcs | Process Industries |
CPH Group AG
 CPH Group AG Containers/PackagingProcess Industries Engages in the manufacturing, developing and distribution of pharmaceutical packaging films and specialty chemicals | Process Industries |
Chemie Uetikon AG
 Chemie Uetikon AG Chemicals: SpecialtyProcess Industries Manufactures sulphuric acid and sulphate compounds | Process Industries |
KPMG Holding AG
KPMG Holding AG Miscellaneous Commercial ServicesCommercial Services Provides accounting services | Commercial Services |
Süd-Chemie Zeolites GmbH | |
Zeochem AG
Zeochem AG Chemicals: SpecialtyProcess Industries Develops and produces chromatography gels | Process Industries |
Sud Chemie UK Ltd. | |
Süd-Chemie Performance Packaging | |
Canexis Pharma AG
Canexis Pharma AG Canexis Pharma AG is a Swiss GMP-certified company specializing in the production of medical cannabis and cannabis-based pharmaceuticals. The company is based in Schlattingen, Switzerland. The company integrates expertise in natural medicine, chemistry, and business informatics to advance cannabinoid science and patient care. Canexis operates a facility featuring cleanrooms and controlled environments compliant with EU and PIC/S GMP standards, and adheres to multiple pharmacopeias including the European, Swiss, and German pharmacopoeias. The company oversees the entire value chain, from seed selection and sustainable cultivation under GACP guidelines with partners, through in-house analytics and quality control, to manufacturing and distribution of active pharmaceutical ingredients and finished medicinal products. Manufacturing processes involve custom-built equipment and controlled steps such as extraction, distillation, and formulation, validated according to regulatory requirements. Canexis holds licenses for manufacturing, wholesale distribution, export, and handling of controlled substances, and offers solutions, training, and consulting in medical cannabis. |
